Probably genetic raises 12m scale rare disease dataset support drug discovery

T2Covered by 1 source · first reported by Fierce Biotech / Fierce Healthcare / MedCity / GEN at 14 Oct, 15:09 UTC

The company’s core product is a physician-ordered genetic test for undiagnosed rare disease patients, who typically face a seven-year diagnostic odyssey before getting answers.

science

Sources

• T2Probably genetic raises 12m scale rare disease dataset support drug discoveryFierce Biotech / Fierce Healthcare / MedCity / GEN14 Oct, 15:09